FR2300550A1 - ANTIMICROBIAL DRUG - Google Patents

ANTIMICROBIAL DRUG

Info

Publication number
FR2300550A1
FR2300550A1 FR7603829A FR7603829A FR2300550A1 FR 2300550 A1 FR2300550 A1 FR 2300550A1 FR 7603829 A FR7603829 A FR 7603829A FR 7603829 A FR7603829 A FR 7603829A FR 2300550 A1 FR2300550 A1 FR 2300550A1
Authority
FR
France
Prior art keywords
antimicrobial drug
antimicrobial
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7603829A
Other languages
French (fr)
Other versions
FR2300550B1 (en
Inventor
Allan John Torode
David Harden
John Spence
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of FR2300550A1 publication Critical patent/FR2300550A1/en
Application granted granted Critical
Publication of FR2300550B1 publication Critical patent/FR2300550B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
FR7603829A 1975-02-13 1976-02-12 ANTIMICROBIAL DRUG Granted FR2300550A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6174/75A GB1533243A (en) 1975-02-13 1975-02-13 Tablet formulation

Publications (2)

Publication Number Publication Date
FR2300550A1 true FR2300550A1 (en) 1976-09-10
FR2300550B1 FR2300550B1 (en) 1979-09-21

Family

ID=9809772

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7603829A Granted FR2300550A1 (en) 1975-02-13 1976-02-12 ANTIMICROBIAL DRUG

Country Status (14)

Country Link
JP (1) JPS51106711A (en)
BE (1) BE838507A (en)
CA (1) CA1052267A (en)
DE (1) DE2605656A1 (en)
DK (1) DK57376A (en)
FI (1) FI760340A (en)
FR (1) FR2300550A1 (en)
GB (1) GB1533243A (en)
HU (1) HU171201B (en)
IE (1) IE42952B1 (en)
IL (1) IL49024A (en)
NL (1) NL7601423A (en)
SE (1) SE7601564L (en)
ZA (1) ZA76829B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0003589A2 (en) * 1978-02-06 1979-08-22 The Wellcome Foundation Limited Antacid tablet formulation

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA822995B (en) * 1981-05-21 1983-12-28 Wyeth John & Brother Ltd Slow release pharmaceutical composition
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
SK282071B6 (en) * 1991-01-30 2001-10-08 The Wellcome Foundation Limited Water-dispersible tablet and its preparation method
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US20040109889A1 (en) 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2230341A1 (en) * 1973-05-23 1974-12-20 Wellcome Found
FR2260993A1 (en) * 1974-02-14 1975-09-12 Wellcome Found

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2230341A1 (en) * 1973-05-23 1974-12-20 Wellcome Found
FR2260993A1 (en) * 1974-02-14 1975-09-12 Wellcome Found

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0003589A2 (en) * 1978-02-06 1979-08-22 The Wellcome Foundation Limited Antacid tablet formulation
EP0003589A3 (en) * 1978-02-06 1979-09-05 The Wellcome Foundation Limited Antacid tablet formulation

Also Published As

Publication number Publication date
AU1110876A (en) 1977-08-18
DE2605656A1 (en) 1976-08-26
IE42952L (en) 1976-08-13
GB1533243A (en) 1978-11-22
DK57376A (en) 1976-08-14
ZA76829B (en) 1977-09-28
JPS51106711A (en) 1976-09-21
NL7601423A (en) 1976-08-17
FR2300550B1 (en) 1979-09-21
IL49024A0 (en) 1976-04-30
FI760340A (en) 1976-08-14
IL49024A (en) 1979-03-12
IE42952B1 (en) 1980-11-19
BE838507A (en) 1976-08-12
CA1052267A (en) 1979-04-10
SE7601564L (en) 1976-08-16
HU171201B (en) 1977-11-28

Similar Documents

Publication Publication Date Title
FR2312259A1 (en) ANTI-TUMOR MEDICINE
SE7803527L (en) DRUG DOSAGE UNIT
DK26976A (en) SYRINGE
SE7611963L (en) SYRINGE
SE7601563L (en) Syringe
BR7600226A (en) MEDICATION SET
SE7709359L (en) PHARMACEUTICAL DOSAGE FORM
FR2311557A1 (en) SYRINGE
BE839632A (en) ZINCIC SULFADIAZINE MEDICINAL PRODUCT
SE409078B (en) Syringe
DK90376A (en) MEDICINE PACKAGING
SE409947B (en) Syringe
SE408266B (en) DRUG EVAPORATORS
FR2307538A1 (en) NEW PLATELET ANTI-AGGREGANT DRUG
SE7601894L (en) THERAPEUTIC MEDICINE
SE7608478L (en) PHARMACEUTICAL
FR2300550A1 (en) ANTIMICROBIAL DRUG
SE7600480L (en) PHARMACEUTICAL USE 2-AMINOACETAMIDO-ALFA-PHENYLBENZYLIDENAMINOALK
DD128671A5 (en) PHARMACEUTICAL AGENTS
FR2314719A1 (en) NEW DRUG, ESPECIALLY DIURETIC
DK446576A (en) ANTIBACTERIAL MEDICINES
MC1044A1 (en) Antimicrobial drug
IT7827782A0 (en) MEDICINAL ASSOCIATION.
RO65632A2 (en) RECONFORTANT MEDICINE
RO77521A2 (en) ANTIRHUMATISMAL DRUG

Legal Events

Date Code Title Description
ST Notification of lapse